BELLUS Well being (TSE:BLU) Share Worth Passes Above Fifty Day Shifting Common of $10.60

BELLUS Health logoBELLUS Well being Inc. (TSE:BLU – Get Ranking)’s share worth crossed above its 50-day transferring common throughout buying and selling on Tuesday . The inventory has a 50-day transferring common of C$10.60 and traded as excessive as C$13.18. BELLUS Well being shares final traded at C$13.18, with a quantity of 168,322 shares.

Individually, HC Wainwright reaffirmed a “purchase” ranking and set a C$16.00 worth goal on shares of BELLUS Well being in a analysis report on Thursday, Could twelfth. 5 analysts have rated the inventory with a purchase ranking, Based mostly on information from MarketBeat.com, BELLUS Well being has a median ranking of “Purchase” and a median worth goal of C$15.75.

The corporate has a present ratio of 15.33, a fast ratio of 14.75 and a debt-to-equity ratio of 0.30. The enterprise’s 50-day easy transferring common is C$10.60 and its two-hundred day easy transferring common is C$9.42. The corporate has a market capitalization of C$1.41 billion and a PE ratio of -12.55.

BELLUS Well being (TSE:BLU – Get Ranking) final posted its quarterly earnings information on Wednesday, Could eleventh. The corporate reported C($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of C($0.23) by C$0.07. The agency had income of C$0.01 million throughout the quarter, in comparison with analysts’ expectations of C$0.01 million. On common, analysts forecast that BELLUS Well being Inc. will submit -0.94 EPS for the present yr.

BELLUS Well being Firm Profile (TSE:BLU)

BELLUS Well being Inc, a scientific stage biopharmaceutical firm, develops therapeutics for the remedy of refractory power cough (RCC) and different cough hypersensitivity indications. Its lead product candidate contains BLU-5937, an antagonist of the P2X3 receptor, which is in Section II scientific trial for remedy of RCC and power pruritus.

Additional Studying

Need Extra Nice Investing Concepts?

Obtain Information & Scores for BELLUS Well being Every day – Enter your e mail handle beneath to obtain a concise every day abstract of the newest information and analysts’ scores for BELLUS Well being and associated corporations with MarketBeat.com’s FREE every day e mail publication.